Frequency Therapeutics, Inc. (FREQ) Income Annual - Discounting Cash Flows
FREQ
Frequency Therapeutics, Inc.
FREQ (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
Report Filing 2025-11-12 2025-03-18 2023-05-01 2022-03-15 2021-03-29 2020-03-26 2018-12-31 2017-12-31
Revenue 7.37 2.27 0 14.07 36.98 28.95 0 0
Cost of Revenue 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 14.07 36.98 28.95 0 0
Operating Expenses 118.4 91.91 83 98.1 64.53 49.62 18.94 16.31
Research & Development 99.72 63.64 49.42 60.92 37.41 18.78 11.88 11.97
Selling, General and Administrative 26.02 30.55 33.58 37.18 27.12 30.84 7.06 4.34
Other Operating Expenses -7.37 -2.27 0 0 0 0 0 0
Operating Income -118.4 -91.91 -83 -84.03 -27.55 -20.68 -18.94 -16.31
Net Non-Operating Interest -1.03 0 0.366 -0.367 0.994 0 -0.106 -0.348
Interest Income -1.32 0 1.33 0.397 0.994 1.78 0 -0.174
Interest Expense -0.284 0 0.961 0.764 0 1.78 0.106 0.174
Equity & Other Income/(Expense) 10.67 8.47 1.05 -0.273 0.08 1.93 -0.118 -3.58
Income Before Tax -108.7 -83.44 -81.58 -84.67 -26.48 -18.75 -19.17 -20.24
Income Tax Expense -0.162 -0.141 -0.002 0.015 0.035 -2.74 -0.118 0
Income Attributable to Non-Controlling Interest 0.282 0.282 0 0 0 0 0.118 0
Net Income -108.8 -83.58 -81.58 -84.69 -26.51 -16 -19.17 -20.24
Depreciation and Amortization -2.37 0 2.38 2.91 -0.08 -0.145 0.654 0.531
EBITDA -120.7 -91.91 -80.62 -81.12 -27.63 -20.82 -18.29 -15.78
Earnings Per Share (EPS) -11.95 -9.37 -2.33 -2.47 -0.82 -0.52 -1.59 -1.68
Diluted Earnings Per Share -11.95 -9.37 -2.33 -2.47 -0.82 -0.52 -1.59 -1.68
Weighted Average Shares Outstanding 9.39 8.92 35.08 34.35 32.25 30.86 12.06 12.06
Diluted Weighted Average Shares Outstanding 9.39 8.92 35.08 34.35 32.25 30.86 12.06 12.06
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program